MAB2

Welcome to the Brand page for “MAB2”, which is offered here for The mark consists of the lower case letter m followed by an upper case letter a followed by a lower case letter b with a superscript 2 following the b.;pharmaceutical, biopharmaceutical and medical preparations, agents and substances, all for treatment of cancer, oncological diseases and disorders, infectious diseases and disorders, inflammation and diseases, disorders and conditions associated with inflammation, inflammatory diseases and disorders, and neurological diseases and disorders; bispecific and multispecific immunoglobulins and antibodies for medical use; products containing multispecific, in particular bispecific, immunoglobulins and antibodies for use in medicine; diagnostic preparations, agents and substances for medical purposes;mab two;biological preparations for scientific, industrial, and research use; bispecific and multispecific immunoglobulins and antibodies, and fragments thereof, for scientific, industrial, and research use; libraries of immunoglobulin and antibody fragments for scientific, industrial, and research use relating to the development of bispecific and multispecific immunoglobulins and antibodies;scientific and technological services, scientific research and design in the field of immunoglobulins and antibodies for medical purposes; scientific research, industrial analysis and research services, in the field of immunoglobulins and antibodies for medical purposes; pharmaceutical, scientific and biopharmaceutical research and development; medical research and development in the field of immunoglobulins and antibodies for medical purposes; drug discovery services; research relating to medicines; research and development of medicines; development of pharmaceutical and biopharmaceutical preparations and medicines;.

Its status is currently believed to be active. Its class is unavailable. “MAB2” is believed to be currently owned by “F-STAR THERAPEUTICS LIMITED”.